Role of opioid peptides in disorders of attention in psychopathology.
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000494:pharmacology; D000328:Adult; D001288:Attention / Q000187:drug effects / Q000502:physiology*; D001931:Brain Mapping; D004723:Endorphins / Q000502:physiology*; D005072:Evoked Potentials, Auditory; D005073:Evoked Potentials, Somatosensory; D005074:Evoked Potentials, Visual; D005260:Female; D006801:Humans; D008297:Male; D009271:Naltrexone / Q000494:pharmacology; D010146:Pain / Q000503:physiopathology; D010446:Peptide Fragments / Q000494:pharmacology; D012559:Schizophrenia / Q000503:physiopathology; D012565:Schizophrenic Psychology
D004723:Endorphins; D010446:Peptide Fragments; C013765:Org 2766; D009271:Naltrexone; D000324:Adrenocorticotropic Hormone